Literature DB >> 15530012

Detection of cefotaxime-resistant CTX-M-3 in clinical isolates of Serratia marcescens.

Mei-Fen Tsou1, Wen-Liang Yu, Siu Wan Hung, Chizh-Ju Chi, Ssu Ching Chen, Lii-Tzu Wu.   

Abstract

Strains of Serratia marcescens (isolated in a hospital during April and August 2000) resistant to ampicillin, chloramphenicol, trimethoprim-sulfamethoxazole, streptomycin, tetracycline, and gentamicin were characterized. Out of a total of 34 clinical isolates 6 (17.6 %) exhibited the extended spectrum beta-lactamases (ESBL) resistance; they were also resistant to cefotaxime (minimum inhibitory concentration, MIC > or = 128 microg/mL) but susceptible to imipenem (MIC < or = 0.5 microg/mL). This multidrug resistance was shown to be transferred by a conjugative plasmid. Transconjugants revealed similar MIC profiles when compared to the parental strains. Isoelectric focusing revealed one major transferable beta-lactamase (pI 8.4) which was further identified as CTX-M-3 by PCR and gene sequencing. The presence of strains with this type of ESBL showed the evolution of bla genes and their dissemination among at least three species of the family Enterobacteriaceae isolated within a single hospital. The predominance of CTX-M type enzymes found in this area of Taiwan appeared to be similar to that described in Poland.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530012     DOI: 10.1007/bf02931608

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  20 in total

1.  CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes.

Authors:  L S Tzouvelekis; E Tzelepi; P T Tassios; N J Legakis
Journal:  Int J Antimicrob Agents       Date:  2000-03       Impact factor: 5.283

2.  Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland.

Authors:  Anna Baraniak; Janusz Fiett; Agnieszka Sulikowska; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

3.  The occurrence of the first two CTX-M-3 and TEM-1 producing isolates of Salmonella enterica serovar Oranienburg in Poland.

Authors:  R Gierczyński; J Szych; A Cieślik; W Rastawicki; M Jagielski
Journal:  Int J Antimicrob Agents       Date:  2003-05       Impact factor: 5.283

4.  Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital.

Authors:  A Pałucha; B Mikiewicz; W Hryniewicz; M Gniadkowski
Journal:  J Antimicrob Chemother       Date:  1999-10       Impact factor: 5.790

5.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

6.  Serratia marcescens bacteremia: clinical features and antimicrobial susceptibilities of the isolates.

Authors:  W L Yu; C W Lin; D Y Wang
Journal:  J Microbiol Immunol Infect       Date:  1998-09       Impact factor: 4.399

7.  Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals.

Authors:  M Quinteros; M Radice; N Gardella; M M Rodriguez; N Costa; D Korbenfeld; E Couto; G Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

8.  Confirmation of extended-spectrum beta-lactamase-producing Serratia marcescens: preliminary report from Taiwan.

Authors:  Wen-Liang Yu; Lii-Tzu Wu; Michael A Pfaller; Patricia L Winokur; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2003-04       Impact factor: 2.803

9.  Enteroaggregative and cell-detaching Escherichia coli strains among Polish children with and without diarrhea.

Authors:  B M Sobieszczańska; J Osek
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

10.  Occurrence of extended-spectrum beta-lactamases among Escherichia coli isolates from hospitalized and healthy children.

Authors:  R Franiczek; B Sobieszczańska; M Grabowski; K Mowszet; T Pytrus
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

View more
  2 in total

1.  Serratia infections in a general hospital: characteristics and outcomes.

Authors:  G Samonis; E K Vouloumanou; M Christofaki; D Dimopoulou; S Maraki; E Triantafyllou; D P Kofteridis; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-10       Impact factor: 3.267

2.  Molecular epidemiology of PER-1 extended spectrum beta-lactamase among gram-negative bacteria isolated at a tertiary care hospital.

Authors:  B Eraç; Z Gülay
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.